End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0128 USD | -27.14% | -49.00% | -40.14% |
06/05 | Curative Biotechnology, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Curative Biotechnology, Inc. has withdrawn its IPO in the amount of $7.999998 million. | CI |
Business Summary
Number of employees: 4
Managers
Managers | Title | Age | Since |
---|---|---|---|
I. Garr
CEO | Chief Executive Officer | 71 | 11/21/11 |
Paul M. Michael
CHM | Chairman | - | - |
Steve Chizzik
IRC | Investor Relations Contact | - | - |
Ron Bordens
PRN | Corporate Officer/Principal | - | 11/21/11 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Cary Sucoff
BRD | Director/Board Member | 71 | 12/22/12 |
Theresa Heah
BRD | Director/Board Member | 46 | 31/03 |
Lawrence Zaslow
BRD | Director/Board Member | - | - |
Paul M. Michael
CHM | Chairman | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 227,000 | 0 | 0 | 69.57 % |
Stock B | 1 | 903,263,385 | 628,416,540 ( 69.57 %) | 0 | |
Stock C | 0 | 30,000,000 | 0 | 0 |
Company contact information
Curative Biotechnology, Inc.
3801 PGA Boulevard Suite 600
33410, Palm Beach Gardens
+
http://www.curativebiotech.comSector
1st Jan change | Capi. | |
---|---|---|
-40.14% | 11.52M | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B | |
-6.26% | 11.42B |
- Stock Market
- Equities
- CUBT Stock
- Company Curative Biotechnology, Inc.